Pacer Advisors Inc. Has $62.35 Million Stake in Envista Holdings Co. (NYSE:NVST)

Pacer Advisors Inc. cut its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 8.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,232,093 shares of the company’s stock after selling 297,734 shares during the quarter. Pacer Advisors Inc. owned approximately 1.88% of Envista worth $62,347,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in Envista during the third quarter valued at approximately $31,000. GAMMA Investing LLC increased its holdings in Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after buying an additional 726 shares during the last quarter. Huntington National Bank raised its position in Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after acquiring an additional 949 shares in the last quarter. Blue Trust Inc. lifted its stake in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares during the period.

Envista Trading Up 0.7 %

Shares of NYSE:NVST opened at $21.59 on Tuesday. The business’s 50 day simple moving average is $20.03 and its 200 day simple moving average is $18.87. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $24.79. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The company has a market capitalization of $3.72 billion, a P/E ratio of -2.78, a P/E/G ratio of 1.88 and a beta of 1.33.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The company had revenue of $601.00 million for the quarter, compared to analysts’ expectations of $590.34 million. During the same quarter last year, the business earned $0.43 earnings per share. Envista’s revenue was down 4.8% on a year-over-year basis. On average, research analysts anticipate that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on NVST shares. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and boosted their target price for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Stifel Nicolaus raised their price target on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Robert W. Baird upped their price objective on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Envista currently has a consensus rating of “Hold” and an average target price of $20.13.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.